MDAI vs BSX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

MDAI

35.9
AI Score
VS
BSX Wins

BSX

41.3
AI Score

Investment Advisor Scores

MDAI

36score
Recommendation
AVOID NEW MONEY

BSX

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MDAI BSX Winner
Forward P/E 52.356 13.2275 BSX
PEG Ratio 0 0.6251 Tie
Revenue Growth -30.4% 7.5% BSX
Earnings Growth 0.0% 15.1% BSX
Tradestie Score 35.9/100 41.3/100 BSX
Profit Margin -65.5% 17.5% BSX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BSX

Relative Price Performance (Last 90 Days)

MDAI 1M: -11.1% · 3M: -12.2% BSX 1M: +2.3% · 3M: +0.4%

Current Technical Phase

MDAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 29

RSI (14): 29.2 · Price: $1.44

BSX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.3 · Price: $45.69

Fundamentals Snapshot

Metric MDAI BSX
Market Cap — —
Forward P/E -4.7 13.5
Trailing P/E — 18.6
Revenue (TTM) — —
Revenue Growth -0.3% 0.1%
Gross Margin 0.4% 0.7%
Operating Margin -1.2% 0.2%
EPS -0.32 2.47
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BSX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.